Loading...
SELX is not a good buy right now. The trend is bearish (stacked bearish moving averages and negative MACD), there are no near-term catalysts (no news), and the latest reported quarter (2023/Q4) still shows deep losses and an extremely weak/negative gross margin. With no Intellectia buy signals and an impatient entry requirement, the odds favor avoiding/ selling rather than buying for a quick move.
Price/Trend: Bearish structure with SMA_200 > SMA_20 > SMA_5, indicating persistent downtrend pressure. Momentum: MACD histogram at -0.0168 (below zero) and negatively contracting—bearish momentum is easing but not reversed. RSI: RSI_6 at 38.17 (neutral-to-weak), not a strong oversold reversal signal. Levels: Pivot 0.823 is above the current price (0.75), acting as overhead resistance. Key support sits near S1 0.73 (then S2 0.674). Resistance levels: R1 0.915, R2 0.971. Pattern-based outlook: Similar-pattern stats suggest a small expected uptick over the next week (+2.49%) but a negative bias over the next month (-4.34%), aligning with the broader bearish setup.
Intellectia Proprietary Trading Signals
with price below pivot resistance (0.823).
Latest quarter: 2023/Q4. Revenue was 9,673,000 (flat YoY per provided data). Profitability remains very weak: Net income -23,707,000 and EPS -1.27, with gross margin at -75.2 (negative), indicating the core business is not generating healthy gross profit. Overall, the quarter does not show improving fundamentals that would justify an impatient buy-for-upside setup.
No analyst rating/price target data provided (likely limited or no Wall Street coverage). Wall Street pro view cannot be validated from the dataset; absence of upgrades/targets removes a common bullish catalyst.
